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Abstract
Background: Killian-Pallister syndrome (KPS) is a rare form of chromosomal mosaicism and is defined by the
existence of an extra chromosome 12 in some cell lines in one individual. The degree of mosaicism varies among
tissues and dictates the clinical presentation of the syndrome. The clinical features of Killian-Pallister syndrome
include mental retardation, typical facial dysmorphism and pigmentation defects.
Case presentation: We present a rare case of Killian-Pallister syndrome with severe form of the disease associated
with isolated growth hormone deficiency and low-rate mosaicism on buccal smear. The absence of a marker
chromosome 12p in lymphocyte cultures and the low degree of mosaicism lead to frequent misdiagnosis of this
condition.
Conclusions: The selection of tissue sampling is crucial in establishing the diagnosis of Killian-Pallister syndrome.
Fluorescent in situ hybridisation on buccal smear remains the golden standard as a screening method if a suspicion
of the syndrome exists.
Keywords: Killian-Pallister syndrome, Isolated growth hormone deficiency, Fluorescent in situ hybridisation, Buccal
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Background
Killian Pallister syndrome (KPS) is a rare chromosomal dis-
order caused by mosaic tetrasomy of 12p. The syndrome
has been described independently by Pallister in 1977 [1],
afterwards confirmed by Killian in 1983 [2]. The incidence
is estimated to be 1/25,000 [http://www.orpha.net],
however these data are still uncertain due to the diagnostic
difficulties and unrecognized cases.
In most cases of KPS, the 12p chromosome is present
in four copies [3]; 12p trisomy or other complex
chromosomal rearrangements involving the short arm of
chromosome 12 have rarely been described [4]. The mo-
saic appearance of isochromosome 12p is tissue-limited
and often absent in blood culture. Therefore the
diagnosis is frequently delayed until the appearance of
clinical features later in life.
The extra chromosome is present in 30–100 % of all
analyzed skin fibroblasts and buccal cells, in 10–100 %
of bone marrow cells and amniocytes, whereas in
lymphocytes the mosaic cell line can be found in 0–2 %
[5–7]. Identifying the condition prenatally often fails,
since the amniotic cell cultures reveal no chromosomal
abnormalities [8].
The clinical presentation is variable, including mild to
severe mental retardation, facial dysmorphism, alteration
in skin pigmentation (both hypo- and hyperpigmentation)
and several nonspecific congenital anomalies. The most
significant features that infer the diagnosis are coarse face,
full cheeks, sparse hair on the lateral sides of the head,
diaphragmal hernias and supernumerary nipples [9].
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mentioned features are highly variable, which makes
the clinical recognition difficult.
Additionally, certain infrequent and subtle features
have been described, such as ear pits, palm vs. finger
length, typical upper lip, offering a full dysmorphological
spectrum of the syndrome [10, 11]. Epileptic seizures,
usually described as generalized or myoclonic, are fre-
quent [12]. Other types of seizures, such as hypsarrhytmia,
are rarely described [13]. Alike other syndromic epilepsies,
the seizures are hard to control, even with combinations
of several antiepileptic drugs.
The growth characteristics in KPS include high birth
weight and high growth velocity during the first months,
followed by growth retardation and delayed bone age
later in childhood. Reynolds [10] suggested that the ini-
tial overgrowth typical of KPS needs further elucidation
since most of the aneuploidies involving other chromo-
somes are associated with fetal growth retardation. It is
likely that the presence of 3 or 4 copies of certain genes
on chromosome 12 provoke fetal overgrowth. Lower birth
measurements combined with microcephaly are rarely
present [9] and are usually associated with additional
anomalies - cardial and intestinal defects, renal cysts, etc.
Some authors suspect that the clinical presentation de-
pends on the degree of mosaicism, while others consider
the size of the supernumerary chromosome i.e., the
number of present gene copies, more important. How-
ever, there are reports of similar degrees of mosaicism
but inconsistent severity of clinical features [11]. Some
authors suggested that existence of the supernumerary
chromosome in particular tissues is responsible for this
clinical range rather than degree of mosaicism [14].
Case presentation
The proband is a 14 month-old girl with short stature
and mental retardation. This was the first child from
healthy unrelated parents. The pregnancy was uneventful;
the baby was delivered naturally at 40 weeks of gestation,
measuring 2,400 g and 45 cm at birth (small for
gestational age). After the delivery generalized hypotonia
and a poor sucking reflex were noticed, therefore the baby
was fed through a nasogastric tube during the first
weeks. During infancy, the growth was continuously
under the 3rd percentile; failure to thrive and developmen-
tal delay were also noticed. Facial dysmorphic features
were present, including: a coarse face, a prominent fore-
head, bitemporally sparse hair, narrow and upslanted pal-
pebral fissures, hypertelorism, a short and upturned nose
with anteverted nares, full cheeks, a long philtrum and
protruding lips (Fig. 1).
Standard chromosome analysis of blood lymphocytes
was performed, with 3-day cultivation using phytohaem-
agglutinin and standard harvesting, followed by G-
banding [15]. A total of 50 metaphases were analysed
using Microscope Olympus BX51 and standard Metasys-
tems karyotyper. The results revealed a normal karyotype
in all analysed cells.
Buccal smear was dissolved in 2 ml 1xPBS solution,
centrifuged and put into fixative (3:1 acetic acid-methanol
solution). After centrifugation and supernatant disposal,
solution of 0,075 M KCL on 37 °C temperature was added
to the sediment. The fixing procedure was repeated two
times successively; afterwards the sediment was trans-
ferred on the slide. The dried slide was placed in solution
of 0,001 N HCL and 100 μl pepsin for 10 min in water tub
on 37 °C. Fluorescent in situ hybridization (FISH) was per-
formed using the centromeric probe (red signal) for
chromosome 12 (12p, Vysis, CEP 12 spectrum orange, cat.
No 30–160012). The standard FISH protocol was used
[16]. The fluorescent light microscope analysis (Olympus
BX51) was performed both on blood leukocytes and buc-
cal smear. Adjacent filters were used – 4’,6-diamidino-2-
phenylindole (DAPI) for the counterstaining, and tetra-
methylrhodamine isothiocyanate (TRITC) for the
visualization of red colour. Computer analysis was done
with Metasystems-FISH software, version 5.5. At least 200
nuclei from each tissue were analysed. The extra 12p sig-
nal was detected in 30 % of the analysed buccal smear
Fig. 1 Facial appearance in our patient
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Fig. 2 FISH for centromeric probe of chromosome 12 performed on buccal smear, showing 3 signals in 30 % of the analyzed cells
Fig. 3 Growth curve representing prenatal and postnatal growth retardation
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cells, but not in the blood leukocyte culture (Fig. 2). The
fibroblast culture was not performed due to the parental
denial and condition of the patient.
At the age of 2.5 years the short stature became more
evident - it was 3.5 SDS below the mean (Fig. 3). GH
stimulation tests were performed, with a peak value of
4.9 ng/ml; insulin-like growth factor 1 (IGF1) was also
below the expected values - under 10 ng/ml (ref. value
24–152 ng/ml for the age). MRI of the pituitary showed
normal structure (Fig. 4). The other pituitary hormone
levels were normal.
At the age of 4 years the child developed clonic-tonic
seizures and her motor and mental abilities started to
deteriorate - she lost some of her previously acquired
achievements. She developed profound mental retard-
ation and incontinence. The seizures were resistant to
anticonvulsive therapy (Fig. 5). Due to the presence of
intractable epilepsy and mental deterioration, GH re-
placement therapy was not initiated. Puberty had an
early onset - at the age of 8.5 years, leading to further
growth delay.
Discussion
Establishing the diagnosis of Killian-Pallister syn-
drome (KPS) is often difficult and demanding, requir-
ing thorough clinical observation and different
cytogenetic and molecular methods. The underlying
mechanism for this rare chromosomal error is prezy-
gotic [17], occurring in maternal meiosis 2 followed
by mitotic loss of the marker chromosome in some
cells. The predominance of the meiosis 2 error in the
formation of i(12p), unlike other chromosomopathies,
is still unresolved. Dufke [18] clarified the smallest
critical region of the chromosome (12pter-12p12.3)
using different molecular-cytogenetic techniques. The
phenotypic characteristics of KPS were confirmed to
be a result of the dosage effect of LDH-B gene in
some cases [19], but others indicate that a fitting
phenotype is possible without the presence of this
gene [18]. In all cases, however, heterozygosity is re-
duced to homozigosity in the derivative chromosome
12. Kaur [20] gives a comprehensive analysis chromo-
some 12 genes that could produce a KPS phenotype,
narrowing the critical region on band 12p13.31. He
Fig. 4 MRI of the brain showing slightly enlarged ventricles and
pituitary gland with no abnormalities
Fig. 5 Right-sided spike-and-wave focus in the fronto-temporo-parietal region, with a short generalized discharge on EEG
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identified several genes that, when misexpressed (either
up or down regulated), yield clinical features of the
syndrome.
The growth curve in KPS patients is biphasic - pre-
natal overgrowth followed by postnatal growth retard-
ation. Although there are several genes on chromosome
12 that promote growth in various tissues (ADIPOR2,
FGF6, NTF3, KRAS1, etc.), there are no specific studies
about the reason for fetal overgrowth in these patients.
Unlike other children with KPS, in our patient growth
retardation was present both prenatally (the baby was
born small for gestational age) and postnatally (constantly
3SDS below the mean). Growth hormone deficiency is an
uncommon finding in KPS, described only once in
the literature [21] and should be further evaluated.
Overexpression of insulin-like growth factor 2 (IGFBP2) is
a probable reason for postnatal growth retardation
[20]. The reason for prenatal growth retardation in our
case is unclear.
The cytogenetic finding of i(12p) is rarely detected
in blood leukocytes. Some speculate that this is due
to the distortion of abnormal cells during the cultur-
ing procedure, during which i(12p) becomes dramatic-
ally reduced [3, 22]. This reduction occurs in vivo as
well; therefore the aneuploidy can be detected in
bone marrow tissue only in the early neonatal period
[23]. In all other tissues that divide less frequently
(i.e.fibroblasts) the extra chromosome persists for lon-
ger periods and can be detected later in life. There-
fore skin biopsy is most reliable method in detecting
the syndrome.
The use of the FISH method in tissues other than
blood leukocytes was first described by Speleman [24]
who detected i(12p) in fibroblasts; the value of the
method was afterwards confirmed by other authors
[25, 26] who used FISH on buccal smear. The method
allows detection of i(12p) on interphase nuclei without
cultivation and is considered to be a reliable, rapid and
effective method for the detection of the chromosomal
abnormality in this syndrome. The presence of low-rate
mosaicism of i(12p) broadens the phenotypic spectrum of
the syndrome. In most of the studies so far [25, 27], an
alpha satellite probe of the centromeric region of chromo-
some 12 was used, but some authors [26, 27] suggest the
usage of a dual colour, locus specific probe in order to
avoid cross-hybridisation with other cetromeres and
false positive results, as well as to detect the number
and length of the supernumerary 12p. Recently, other
methods such as array CGH are proposed as more
sensitive [14, 22]; however these methods are more
expensive, require more sophisticated equipment and
could not be used as a screening procedure. Yet essential
for diagnosis is not the method used, but the adequate
choice of tissue for sampling.
Conclusions
The FISH method on buccal smear remains invaluable
for the detection of Killian-Pallister syndrome. In order
to avoid diagnostic delay and invasive diagnostic proce-
dures, the buccal smear FISH analysis remains a super-
ior method due to the less invasive nature of sample
collection.
Underlying mechanisms of the biphasic growth pattern
in Killian Pallister syndrome are not yet elucidated and
need further investigations. Rarely, both prenatal and post-
natal growth pattern are affected and could be associated
with growth hormone deficiency, as shown in our case.
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